- Training missions: – Organize training actions for the medical and paramedical staff – Share specific knowledges on ALS patient’s care – Participate in and get involved in working groups during the coordination symposium of French ALS centres.
- Research missions: – Ensure clinical research activities through the establishment of internal and multicenter research protocols: area of research: epidemiology, cognition and nutrition – Participate in therapeutic research in collaboration with the pharmaceutical industry – Communicate the results of research through oral or displayed communications – Publish the results of research into national and international levels
Philippe CouratierProfessor of Neurology
Professor Philippe Couratier is Neurologist in the University Hospital of Limoges.
TUDCA (tauroursodeoxycholic acid) is a small molecule that is being explored for its potential as a treatment for ALSRead more
PreLude (Lithium carbonate)
Within an innovative platform design study, we will evaluate the efficacy of lithium carbonate in UNC13a homozygous patients.Read more
Within an innovative platform design study, we will evaluate the efficacy of Triumeq, a therapy developed for treatment of HIV that has shown to slow progression in ALSRead more
iAdore (Oral edaravone)
Within an innovative platform design study, we will evaluate the efficacy of oral edaravone (TW001), a formulation that reduces oxidative stressRead more